Simon P. Kim, MD, MPH is a urologic oncologist at UH Cleveland Medical Center, and Assistant Professor, Urology, Case Western Reserve University School of Medicine. He is also the Co-director, Center for Quality and Outcomes, Urology Institute, Cleveland, Ohio.
His clinical practice focuses on the surgical management of genitourinary malignancies. He specializes in the surgical treatment of bladder, kidney, prostate, and testis cancer. He performs both robotic and open surgery for localized or locally advanced cancers.
Dr. Kim’s research focuses on improving the quality of care and health outcomes for patients diagnosed with prostate, bladder and kidney cancer. He also has research interests in shared decision-making and health services research.
Dr. Kim was recently awarded a career development award from the Conquer Cancer Foundation of the American Society of Clinical Oncology. He has been independently funded from the NIH to develop decision aids for men diagnosed with localized prostate cancer. He has published more than 100 manuscripts in outcomes research for genitourinary cancer and was awarded the Journal of Urology Best Reviewer Award in 2013.
Dr. Kim completed his undergraduate work at University of Rochester, Rochester, New York, and earned his Master of Public Health from University of Illinois, Chicago, Illinois. He earned his medical degree from Chicago Medical School, North Chicago, IL, where he was elected to the Alpha Omega Alpha Honor Medical Society. Dr. Kim completed his residency in urology at University of Michigan, Ann Arbor, Michigan and was a Research Scholar in the Healthcare Delivery and Research Program, Mayo Clinic, Rochester, Minnesota. He was also a Urologic Oncology Fellow, Clinical Instructor in Urology, Mayo Clinic, Rochester, Minnesota.
American Board of Urology - Urology
Education & Training
1995, University of Rochester
Medical / Professional School(s)
2004, Chicago Medical School/Rosalind Franklin Univ of Medicine and Science
2010, Urology - University of Michigan Medical Center/University of Michigan Health System
2013, Urologic Oncology - Mayo Clinic
Urology, Urologic Oncology, Bladder Cancer, Kidney Cancer, Prostate Cancer, Testicular Cancers, Robotic Surgery, Penile Cancer, Locally Advanced Cancer
Awards & Recognition
- The Journal of Urology Best Reviewer Award in 2013
- Bronze Beeper – Excellence in Teaching University of Michigan Medical School
- Board of Trustees Scholarship Award Chicago Medical School
- Alpha Omega Alpha Honor Medical Society
- Cum Laude University of Rochester
- High Distinction in Health and Society University of Rochester, Rochester
UH Cleveland Medical Center
Department of Urology
11100 Euclid Ave
1611 S Green Rd
University Suburban Health Center, Ste 106
UH Chagrin Highlands Health Center
3909 Orange Pl
Prostate, bladder and kidney cancer, Shared decision-making, Health services research
Patient Satisfaction Reviews
About Our Survey
At University Hospitals, we believe in providing patients with all the information they need to make educated decisions
about their health care and to choose the right doctor to meet their needs. That is why we partner with the independent
patient satisfaction company Press Ganey to survey patients about their experiences at UH facilities and with UH physicians.
We hold ourselves to the highest standards of care and are dedicated to creating a positive patient experience for
every individual who sees a UH doctor.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2015, Simon Kim, MD, MPH did not disclose any Outside Relationships with Industry.